Add to ORKGRD&E staff can access the full-text of this article via OpenAthens. Click on the 'Additional Link' above to access the full-text and log in with NHS OpenAthens if prompted
Narcolepsy is characterized as a sleep disorder that af-fects approximately 0.05 % of the population...
Study Objectives: To evaluate adherence to sodium oxybate prescribing information for indication and...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
RD&E staff can access the full-text of this article via OpenAthens. Click on the 'Additional Link' a...
This article is available to RD&E staff - click on the Publisher's link above, and log in with NHS O...
none25Pubblicata nella rubrica "Letters to the Editor"noneLammers G.J.; Bassetti C.; Billiard M.; Bl...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Background: Narcolepsy is a lifelong neurological disorder with onset commonly in childhood or adole...
Contains fulltext : 98354.pdf (publisher's version ) (Open Access)OBJECTIVE: Hypoc...
Lower-sodium oxybate (LXB) is an oxybate medication approved to treat cataplexy or excessive daytime...
RD&E staff can access the full-text of this article by clicking on the 'Additional Link' above and l...
Narcolepsy is a neurological disorder characterized, in its classical form, by excessive daytime sle...
Gamma-hydroxybutyrate (GHB) is a short chain fatty acid endogenously produced within the central ner...
Background: Narcolepsy is a chronical neurological disease with a prevalence of 0,02-0,05 % in the w...
none4noReviewBackground: Narcolepsy type 1 (NT1) is a chronic neurologic disorder defined by excessi...
Narcolepsy is characterized as a sleep disorder that af-fects approximately 0.05 % of the population...
Study Objectives: To evaluate adherence to sodium oxybate prescribing information for indication and...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...
RD&E staff can access the full-text of this article via OpenAthens. Click on the 'Additional Link' a...
This article is available to RD&E staff - click on the Publisher's link above, and log in with NHS O...
none25Pubblicata nella rubrica "Letters to the Editor"noneLammers G.J.; Bassetti C.; Billiard M.; Bl...
<p><b>Article full text</b></p> <p><br></p> <p>The full text of this article can be found here<b>....
Background: Narcolepsy is a lifelong neurological disorder with onset commonly in childhood or adole...
Contains fulltext : 98354.pdf (publisher's version ) (Open Access)OBJECTIVE: Hypoc...
Lower-sodium oxybate (LXB) is an oxybate medication approved to treat cataplexy or excessive daytime...
RD&E staff can access the full-text of this article by clicking on the 'Additional Link' above and l...
Narcolepsy is a neurological disorder characterized, in its classical form, by excessive daytime sle...
Gamma-hydroxybutyrate (GHB) is a short chain fatty acid endogenously produced within the central ner...
Background: Narcolepsy is a chronical neurological disease with a prevalence of 0,02-0,05 % in the w...
none4noReviewBackground: Narcolepsy type 1 (NT1) is a chronic neurologic disorder defined by excessi...
Narcolepsy is characterized as a sleep disorder that af-fects approximately 0.05 % of the population...
Study Objectives: To evaluate adherence to sodium oxybate prescribing information for indication and...
The article is available via Open Access. Click on the 'Additional link' above to access the full-te...